Clinical Trials Browser

Phase 2 × Withdrawn × Sirolimus × Clear all

NCT01843998 2015-06-04

Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)

Phase 2 Withdrawn

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT01851408 2015-04-15

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Phase 2 Withdrawn

Melanoma, Recurrence